DOH to stop administering anti-HIV drugs lopinavir, ritonavir in COVID-19 treatment trials | Inquirer News

DOH to stop administering anti-HIV drugs lopinavir, ritonavir in COVID-19 treatment trials

By: - Reporter / @DYGalvezINQ
/ 02:21 PM July 05, 2020

MANILA, Philippines — The Department of Health (DOH) will stop administering to hospitalized COVID-19 patients anti-HIV drugs lopinavir and ritonavir in its trials for the coronavirus disease treatment.

This is after the World Health Organization announced it will discontinue its trials of the combination HIV drugs, along with malaria drug hydroxychloroquine after they failed to reduce mortality rate.

“Based on the recent evidence and recommendations from our experts, we will be stopping the use of lopinavir and ritonavir among hospitalized patients,” Health Undersecretary Maria Rosario Vergeire told reporters in a text message.

Article continues after this advertisement

“We have already discontinued Hydroxychloroquine early on when the evidence for this came out,” she added.

FEATURED STORIES

Under the WHO’s Solidarity Trial, to which the Philippines is participating, four drugs are being eyes as treatment for COVID-19: the antimalaria drug hydroxychloroquine, remdesivir, the anti-HIV drugs lopinavir and ritonavir or a combination of the two, and interferon.

Last May, the DOH temporarily paused administering the anti-malarial drug hydroxychloroquine to patients as a treatment for coronavirus disease after WHO halted its use due to evidence that people taking the drug were at higher risk of incurring heart problems, or even of death.

Article continues after this advertisement

In June, WHO altogether halted the trials for hydroxychloroquine after finding that it did not reduce mortality rate

Article continues after this advertisement

The trial for the said drug was resumed after safety review.

Article continues after this advertisement

Last Thursday, Vergeire said antiviral drug remdesivir has so far shown “positive effects” on some patients taking it.

However, such findings are not conclusive yet.

JE
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, DoH, Drugs, Trial

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.